The work examines how cells in the body communicate with each other through cytokines, signaling molecules that direct a wide range of activities such as cell growth and movement. One important cytokine -- transforming growth factor -a (TGF-a) -- normally suppresses tumor development.
However, according to the findings, cancer cells in humans are able to misuse these cytokines for their own gain by compelling TGF-a to enhance a tumor's ability to spread instead of suppressing it.
Using computer-based analysis to classify patient tumor samples based on their levels of TGF-a, the researchers observed that about half of all breast tumors contained active TGF-a. The affected tumors were found to be more aggressive and more likely to metastasize to the lung during the course of the patients' disease.
Using mice for their next set of experiments, the researchers discovered that TGF-a prompts breast cancer cells to make a second cytokine, known as angiopoietin-like 4 (ANGPTL4), which enhances the ability of the cancer to spread to the lungs through the blood circulation. The results show that the breast cancer cells use ANGPTL4 to break down the thin capillaries of the lung, thus facilitating their escape into the lung tissue.
"Our work shows that TGF-a enhances human breast cancer metastasis and reveals how tumor cells learn to exploit cytokines by making them work as a relay system to promote the spread of breast cancer," said the study's senior author, Joan Massagu¨¦, PhD, Chairman of the Cancer Biology and Genetics Program at MSKCC and a Howard Hughes Medical Institute investigator.
The researchers are now seeking to determine whether TGF-a and ANGPTL4 may also be active in other types of tumors, and are evaluating ways to interfere with the action of these cytokines to prevent metastasis in cancer patients.
"Deciphering how cancer cells take advantage of these cytokines is essential for developing therapies that can prevent this process," said the study's lead author David Padua, a graduate student in Dr. Massagu¨¦'s lab. "Because cytokines act outside of cells they can be more easily targeted by drugs that block their activity."
The study provides support for developing agents to interfere with TGF-a in order to prevent and treat cancer metastasis. It points at ANGPTL4 as a possible target to interrupt the TGF-a stimulus of metastasis without interfering with the molecule's beneficial effects. Several pharmaceutical companies are currently testing TGF-a-blocking compounds in clinical trials as candidate drugs against breast cancer, melanoma, and other types of cancer.
Esther Napolitano | EurekAlert!
The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung
A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Studies and Analyses
19.01.2017 | Physics and Astronomy
19.01.2017 | Life Sciences